The novel serotonin subtype-4 (5-HT 4 ) receptor agonist, SC53116 (SC), produced a limited relaxation of noradrenaline (NA) pre-contracted human corpus cavernosum (CC) smooth muscle in vitro. This effect was not signi®cantly attenuated by the 5-HT 4 antagonist SDZ250557 (SDZ). In the presence of ( AE ) pindolol (1 mM) and methysergide (1 mM), employed to mask 5-HT 1 and badrenergic, and 5-HT 2 receptors respectively, SC failed to relax NA pre-contracted CC strips to a greater extent than saline. Functional cAMP dependent relaxation pathways were demonstrated by a signi®cant reduction in NA induced tone by prostaglandin E 1 (PGE 1 ) and isopropylnoradrenaline (IPNA), the action of the latter compound was effectively eliminated in the presence of ( AE ) pindolol. Relaxation of NA induced tone caused by the nitric oxide donor nitro-glycerine (NTG) was signi®cant and similar in the absence and presence of the 5-HT and b-adrenergic antagonists. The results of this present study indicate that human corporal smooth muscle does not contain 5-HT 4 receptors and that, although compounds like SC act to relax non-vascular smooth muscle via cAMP dependent mechanisms, 5-HT 4 receptor agonists may be expected to be of limited utility in triggering cAMP dependent relaxation responses in human CC.
Introduction
Satisfactory erectile function is critically dependent on the proper responses of corpus cavernosum (CC) smooth muscle to the balance of contractile and relaxant neurogenic inputs. 1 Reduced penile blood ow resulting from insuf®cient CC smooth muscle relaxation has been implicated in the development of erectile dysfunction secondary to a number of pathophysiological states, drug treatments or surgical procedures. 2 ± 4 In such cases the use of direct acting CC smooth muscle relaxants is a useful approach in the treatment of erectile dysfunction. 5, 6 Previous work has shown that prostaglandin E 1 , (PGE 1 ) is a safe and ef®cacious CC smooth muscle relaxant. 7, 8 The mechanism by which PGE 1 produces its bene®cial effects is through activation, via a G-protein coupled prostanoid receptor, of adenylate cyclase and stimulation of intracellular cAMP production. 9, 10 Recently serotonin receptors mediating non-vascular smooth muscle relaxation through a similar mechanism have been described by molecular and pharmacological techniques and named 5-HT 4 based on their unique pharmacological pro®le. 11, 12 The search for novel 5-HT compounds for use in the treatment of erectile dysfunction is a part of our laboratory's on-going research. 13 ± 16 5 -HT receptors are a large family (more than 14 different subtypes) of G-protein coupled receptors (with one ligand gated ion channel) that mediate very diverse physiological functions. 17, 18 In many cases these physiological functions are mediated through changes in adenylate cyclase and cAMP activity. 19 We have found no reports in the literature concerning the effects of subtype selective 5-HT agonists or antagonists that interact with adenylate cyclase (AC) and cAMP on CC smooth muscle contraction and relaxation. Therefore we have employed the novel 5-HT 4 agonist SC53116 and antagonist SDZ250557 (Figure 1 ) in an attempt to determine if 5-HT 4 receptors coupled to cAMP release mediate smooth muscle relaxation in the human CC (Figure 2 ).
Methods
Thirty-seven strips of human CC smooth muscle were prepared from specimens obtained from four patients undergoing gender reassignment. Individual strips were mounted under a resting tension of 1.0 ± 1.5 g in 10 or 25 ml organ baths containing Carbogen 1 (95% O 2 , 5% CO 2 ) gassed Krebs-Henseleit solution maintained at 37 C. After preparation, and prior to initiation of drug testing, CC strips were allowed to equilibrate at resting tension for 1 h with exchange of bath solution at 15 min intervals.
To begin the experiments, strips were exposed twice at hourly intervals to increasing logarithmic concentrations of NA from 10 79 ± 10 74 M. In preliminary studies, in the absence of ( AE ) pindolol and methysergide, the effects of SC and SDZ on CC smooth muscle relaxation were examined. CC strips were pre-contracted with a submaximal concentration of NA (10 75 M) followed 5 min later by addition of SC (10 710 ± 3610 76 M) at 2 ± 3 min intervals in the presence of saline or SDZ. Similar experiments were conducted for the standard CC smooth muscle relaxants IPNA (10 77 ± 10 74 M) and NTG (8610 79 ± 8610 77 M). In the absence of 5-HT and b-adrenergic antagonists SC was also examined for its effect on relaxation of NA pre-contracted CC strips induced by electrical ®eld stimulation (EFS; 70 Volts, 1 msec, 8 Hz, 10 ± 15 s). Five minutes after addition of NA strips were subjected to EFS at a frequency of 8 Hz, three times at 2 min intervals, prior to the addition of SC at 10 710 , 10 78 or 10 76 M. Two minutes after addition of SC EFS induced relaxation was then reassessed in the same manner.
Subsequent experiments were conducted in the presence of 1 mM ( AE ) pindolol and methysergide in . In order to assess the effects of SC on EFS induced relaxation under these conditions experiments were conducted using NA precontracted CC subjected to EFS over a large frequency range (1 ± 32 Hz, 70 V, 1 msec; 10 ± 15 s). Frequency response curves were constructed 7 min after the addition of NA and 2 min after incubation with SC (10 710 ± 10 76 M).
In experiments employing NA pre-contracted CC to explore concentration-dependent relaxation caused by SC or standard corporal smooth muscle relaxants data are expressed as the percentage relaxation of the maximal response elicited by a submaximal concentration of NA, or as the absolute reduction in grams tension. For experiments in which EFS induced relaxation was employed data are expressed as the percent relaxation of the maximal reduction in NA induced tone produced by a stimulation frequency of 32 Hz.
Data was expressed as the mean AE the standard error of the mean (s.e.m.) for 5 ± 16 strips from four specimens of corpus cavernosum. Curve ®ts for concentration-and frequency-response data were generated from a four parameter logistic equation. Frequencies for half maximal reduction in NA induced tone (EF 50 ) were calculated from curve ®ts to individual frequency-response relationships. Data were compared by students t-test or ANOVA with P`0.05 taken as a signi®cant result.
Results
In preliminary experiments in which no attempt was made to mask 5-HT or b-adrenergic receptors SC, at the highest concentration tested (3610 76 M), caused a slight reduction of NA induced tone of 7 20 AE 5% from a pre-contracted maximum of 10.7 AE 1.1 g tension. In the presence of a single concentration of SDZ250557 (1.5610 76 M) SC reduced NA tone by 7 17 AE 5.0% from a pre-contracted maximum of 10.6 AE 1.4 g tension. The maximal effect of SC in the presence and absence of SDZ was not signi®cantly different ( Figure 3A ; P b 0.50 for maximal relaxation). The relaxant effect of SC was less marked than relaxation caused by the b-adrenergic agonist IPNA (10 74 M) or the nitric oxide donor NTG (8610 77 M) which, under similar conditions, produced relaxation of 7 30.5 AE 4.4% and 7 57.7 AE 3.7% respectively from pre-contracted maxima of 10.5 AE 0.7 g tension and 11.2 AE 4.1 g tension respectively. SC was also unable to enhance EFS induced relaxation of NA pre-contracted CC at a submaximal stimulation frequency of 8 Hz ( Figure  3B ; P b 0.10 for pre-drug vs post-drug comparisons at all concentrations).
In time and volume controlled experiments in which ( AE ) pindolol and methysergide were employed SC failed to relax NA induced tone to a signi®cantly greater extent than saline ( 7 24.4 AE 3.3%) in the presence ( 7 22.8 AE 2.1%) or absence ( 7 23.6 AE 2.1%) of SDZ ( Figure 4A ). Under these experimental conditions 5-HT also failed to relax CC strips to a greater extent than saline producing a maximal reduction of NA induced tone of 7 22.4 AE 2.5%. The relaxant responses to a maximal concentration of IPNA ( 7 20.4 AE 1.7%) were diminished compared to the same responses in the absence of ( AE ) pindolol ( 7 30.5 AE 4.4%). Relaxant responses of human CC to a maximal concentration of NTG were unaffected by the presence of 5-HT and b-adrenergic antagonists with an observed reduction of NA induced tone of 68.2 AE 11.7%. Functional cAMP dependent pathways were clearly demonstrated by the signi®cant relaxation of 7 45.0 AE 3.9% induced by PGE 1 ( Figure 4A ; P`0.05 vs saline treated strips). Baseline tensions and maximal responses to NA were not signi®cantly different between treatments (Table 1) .
SC also failed to signi®cantly enhance EFS induced relaxation of NA pre-contracted strips over a large frequency range ( Figure 4B ). EF 50 estimates for half maximal relaxation of NA induced tone were 3.3 AE 1.3 Hz and 3.7 AE 2.3 Hz, 1.7 AE 0.4 Hz and 3.8 AE 1.9 Hz for saline and SC (10 710 , 10 78 and 10 76 M respectively) treated strips respectively (Table 2 ; P b 0.70 vs saline treated strips).
Discussion
Corporal smooth muscle relaxation is an integral part of the erectile process. 1 Neurotransmitters mediating CC smooth muscle relaxation (for example acetylcholine and nitric oxide) are released in response to activation of efferent components of the parasympathetic nervous system and are therefore necessary for normal erectile function. 8 However in cases where normal CC smooth muscle responses have been impaired (for example diabetic peripheral neuropathy, surgical neuropathy and drug treatment) erectile function can be maintained through the use of CC muscle relaxing substances which may not be released in the normal neurogenic erectile response. 2, 3 Prostaglandin E 1 is an example of such a compound, and has wide spread utility in the treatment of erectile dysfunction. 7, 8 The mechanism whereby PGE 1 exerts its CC muscle relaxing actions is believed to be a result of altered membrane ion ux which is directly attributable to intracellular 4 serotonin receptors have been characterized both pharmacologically and biochemically and are believed to be positively coupled to adenylate cyclase and cAMP production 11, 12 (see Figure 2) . Therefore agonists acting at 5-HT 4 receptors mediating smooth muscle relaxation in the CC could in principle be exploited for intracavernosal injection andaor transurethral pharmacotherapy for the treatment of erectile dysfunction. However the results of the present study, using the selective 5-HT 4 agonist and antagonist SC53116 and SDZ250557 respectively, indicate that 5-HT 4 receptors do not exist in human CC smooth muscle.
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Conclusions
The CC smooth muscle relaxing actions of SC53116 were limited and were not antagonized by SDZ250557. Furthermore the limited relaxing actions of SC53116 were not apparent in experimental conditions in which 5-HT 1 and 5-HT2 receptors were masked. Therefore in the absence of 5-HT and badrenoceptor antagonists the limited effects of SC53116 may have resulted from time and bath volume changes or actions at other receptors. Although SC53116 displays a two-fold greater af®nity for 5-HT 4 receptors compared to the 5-HT 4 agonist cisapride, its selectivity ratio for 5-HT 4 vs 5-HT 3 receptors is still less than 10. 22 Evidence for a lack of functional CC 5-HT 4 receptors was obtained by the observed absence of relaxing actions of 5-HT in time and volume controlled experiments in the presence of 5-HT 1 and 5-HT 2 receptor blockade. These observations indicate that a ligand triggering second messenger release in one cell or tissue does not necessarily ful®l the same criteria in other tissues and, are in line with previous experiments showing tissue and species selectivity in the actions of 5-HT 4 agonists in vitro. 23 The results of this present study are in agreement with, and extend, previous work concerning a lack of 5-HT coupled cAMP pathways in cultured human CC smooth muscle cells. 24 As such 5-HT 4 receptors, although positively coupled to cAMP production in other tissues, appear to be absent in human CC. Table 2 Relaxation responses of noradrenaline pre-contracted (max ± NA; 10 75 M) human corporal smooth muscle in response to electrical ®eld stimulation (max ± EFS; 1 ± 32 Hz, 70 V, 1 msec, 10 ± 15 s). Data derived from curve ®ts of individual frequency-response curves to a fourth order logistic function of the form y constant max (1 (frequencyaEF 50 ) slope) are also presented (max (%), EF 50 (Hz) and slope (n)). All values represent the mean AE s.e.m. for 5 strips from four specimens. ANOVA (P) was used to locate signi®cant effects of drug treatment
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